L-LACTATE Dehydrogenase antibody | AbD13978

100% Secure


Human anti Plasmodium vivax LDH:HRP

Product Type
Monoclonal Antibody
Clone
AbD13978
Isotype
IgG1
Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
HCA155P E 0.1 mg
Human anti plasmodium vivax LDH, clone AbD13978 recognizes LDH (L-lactose dehydrogenase) from the Malaria causing protozoan species Plasmodium vivax. It was shown to cross-react with Plasmodium falciparum LDH.

Clone AbD13978 was selected by phage display under heat stress conditions. The Tm value for thermal denaturation of the antibody was measured by CD spectroscopy and has been found to be 70 °C.

Product Details

Target Species
Protozoan
Product Form
Human IgG1 antibody (kappa light chain) selected from the HuCAL ® phage display library and expressed in a human cell line. Conjugated to horseradish peroxidase (HRP) - liquid.
Preparation
Purified IgG prepared by affinity chromatography on Protein A
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.01% Thiomersal
HRP Stabiliser (BUF052A)
Immunogen
Recombinant LDH fusion protein from Plasmodium vivax.
Approx. Protein Concentrations
IgG concentration 0.1 mg/ml

Storage Information

Storage
Store at +4oC. DO NOT FREEZE.
This product should be stored undiluted.
Shelf Life
12 months from date of despatch

More Information

UniProt
P13774 Related reagents
Q4PRK9 Related reagents
GO Terms
GO:0004459 L-lactate dehydrogenase activity
GO:0006096 glycolysis
GO:0055114 oxidation-reduction process
Acknowledgements
Sold under license of U.S. Patents 6753136, 7785859 and 8273688 and corresponding patents. This antibody was developed by Bio-Rad, Zeppelinstr. 4, 82178 Puchheim, Germany.
Licensed Use
For in vitro research purposes only, unless otherwise specified in writing by Bio-Rad.
Regulatory
For research purposes only

Applications of L-LACTATE Dehydrogenase antibody

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
ELISA
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Technical Advice
Recommended protocols and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual